Pfizer vaccine through COVAX, introduced from late February to early March… Prime Minister “Prepare carefully”

Input 2021.02.09 17:16 | Revision 2021.02.09 17:28

Pfizer Vaccine Adoption May Be Late Than AstraZeneca

On the 9th, Prime Minister Jeong Sye-gyun said about the timing of introducing 117,000 doses (585 million people) of Pfizer’s vaccine through’COVAX Facility’, an international project for vaccine joint purchase and distribution. I expect.”

Prime Minister Chung said at the vaccine/treatment situation check meeting presided over at the government’s Sejong Government Complex on the same day and said, “Whatever the vaccine that starts vaccination, the entire process from introduction, transportation, storage, and the first vaccination is carried out according to the vaccination plan that has been prepared. We are preparing carefully,” he said.

It is known that the introduction of Pfizer vaccine through COVAX will be available in early February. However, Prime Minister Chung said that the expected timing of the introduction on the 31st of last month was’mid-February’. This time, it was delayed again to the end of February. In this case, the Pfizer vaccine may be introduced later than the AstraZeneca vaccine, which will begin supplying from the 24th and will begin on the 26th.

There are disagreements over the AstraZeneca vaccine permitting vaccination for the elderly. Some European countries, such as Germany and France, have restricted vaccination for the elderly. Prime Minister Chung ordered, “The Ministry of Food and Drug Safety and the Korea Centers for Disease Control and Prevention should inform the public of the results of the discussion promptly and transparently,” regarding issues such as vaccination for the elderly and the effectiveness of mutant viruses and whether AstraZeneca vaccine is licensed.

In addition, Prime Minister Chung ordered, “To prevent unnecessarily spreading public anxiety, correct false information and fake news promptly and respond strictly.” He said, “As the government has promoted the introduction of various types of vaccines in preparation for various risks, please take measures to ensure that there is no disruption in the formation of group immunity in November by quickly and flexibly adjusting the vaccination plan if necessary.”

Prime Minister Chung mentioned Celltrion’s Corona 19 antibody treatment, which was licensed for use by the Ministry of Food and Drug Safety last week, and said, “The quarantine authorities ask the quarantine authorities to take the necessary follow-up measures promptly so that patients can be prescribed timely and recover.”